Introduction
Melanocytoma is a variant of melanocytic nevus and is most often localized in the optic disc, although it can occur anywhere in the uveal tract [5, 7] . Melanocytoma of the optic disc is a benign melanocytic tumor that rarely causes visual impairment, but it can cause an afferent pupillary defect and a visual field abnormality [2, 4] . When visual loss occurs, it is more likely due to necrosis of the benign tumor and loss of optic nerve function or compression of adjacent blood vessels producing retinal vein or artery occlusion rather than to malignant transformation [8] . Proliferation of choroidal neovascularization on the surface of these lesions has been described in a limited number of cases and formerly constituted an indication for enucleation due to suspected melanoma [1, 6] . To our knowledge, this is the first case of peripapillary choroidal neovascular membrane (PCNVM) associated with a melanocytoma of the optic disc that has successfully been treated by submacular surgery.
Case report
A 45-year-old southern European patient was referred to our department for evaluation and treatment of a recently discovered pigmented mass on the optic disc of the left eye that had been causing a severe loss of visual function for 1 month. Best corrected visual acuity of the affected eye was 20/60. Slit lamp examination was normal and intraocular pressure was 16 mmHg in both eyes. Visual field showed a peripapillary scotoma and a small superior temporal defect. The lesion was located in the temporal sector of the optic nerve and had a choroidal extension, and an intraretinal component with a feathery margin, compatible with its location in the nerve fiber layer (Fig. 1a) . A large subretinal neovascular membrane was situated between the optic nerve and the fovea. On both fluorescein and indocyanin green (ICG) angiography the neovascular membrane extended from the optic nerve to half the surface of the fovea. The tumor's thickness was 2.0 mm on B-scan ultrasonography. The diagnosis of a presumed melanocy-toma complicated by neovascularization phenomena was retained and since there was a relatively good residual visual acuity, a periodic observation was decided upon. Three months after the initial examination, visual acuity, the size, and the shape of both tumor and PCNVM remained unchanged.
After 5 months of follow up, visual acuity decreased to 20/100 and an increased size of the arcuate scotoma and peripapillary defect was observed. Fundus examination showed a large subretinal hemorrhage, and fluorescein and ICG angiography revealed an enlarged extension of the PCNVM to the entire fovea (Fig. 1b) . There was no posterior vitreous detachment. The tumor dimensions remained stable. The extensive size of the PCNVM was not accessible to laser treatment as the surface to be treated would have impinged on the macula. Thus, we decided to perform surgical excision of the PCNVM.
A three-part pars plana vitrectomy was performed by one of the authors (EHB). The retinotomy was made at the superior aspect of the neovascular complex, parallel to the nerve fiber bundle, and the neovascular membrane was grasped and removed in a single piece. The posterior hyaloid was adherent to the subretinal hemorrhage and to the surrounding retina. The histopathologic examination showed a single ingrowth stalk of a dense, vascularized fibrous tissue, situated in the interface of a degenerated retinal pigment epithelium and an atrophic, disorganized gliotic retina (GFAP positive). Neovessels did not invade the retina and Bruch's membrane was not included in the neovascular complex (Fig. 2a,b) . A large vascularized cluster of densely pigmented polyhedral melanocytic cells was present beneath and above the retinal pigment epithelium. The nuclei were small and regular with no prominent nucleoli. No mitotic figures were seen (Fig. 2c) . On immunohistochemistry, the cells stained positive for HMB45 and Melan-A (Fig. 2d) .
Fourteen months after surgery, visual acuity improved to 20/25 and the visual field defect decreased (Fig. 1c) . The retina was attached, the dimensions of the tumor remained stable and fluorescein angiography did not reveal any recurrence of the PCNVM.
Discussion
Development of choroidal neovascularization related to melanocytoma is a rare phenomenon and it can lead to severe loss of visual function. This situation can be differentiated from a malignant transformation by the constant size of the tumor. We are unaware of previous reports of PCNVM related to a melanocytoma of the optic disc that was successfully removed by submacular surgery.
Peripapillary melanoma with disruption of the Bruch's membrane can mimic a melanocytoma of the optic disc. It has one choroidal part and an extension into the vitreous cavity at the junction of the retinal pigment epithelium and the optic disc. However, peripapillary melanoma with disruption of the Bruch's membrane would have an extended choroidal part associated with alterations of the pigment epithelium, lipofuscin deposit, and show as a The histopathology of uveal melanocytoma was clearly defined by Juarez and Tso in 1980 [3] . Two types of cells were recognized. Type 1, which generally predominates, is a larger polyhedral, densely pigmented cell, with a small, bland nucleus, occasionally showing a small nucleolus. Type 2 is a smaller, less pigmented spindle cell, with a more conspicuous nucleolus. Neither type shows mitoses. These two types of cells are generally intermingled. In our case, the bleached preparation of the tumor showed the typically abundant cytoplasm and the small, bland nucleus of the type 1 cell.
Because PCNVM usually begins well away from the fovea, patients suffering from these neovascular membranes typically remain asymptomatic until the extension of the lesions themselves or associated subretinal fluids or blood begin to impinge on the fovea. In patients with good residual visual acuity, the laser required for the ablation of these large neovascular complexes close to the optic nerve and the fovea would destroy the maculo-papillar bundle, and endanger the optic nerve. Therefore, in selected cases submacular surgery is a valuable therapeutic modality. 
